-- 週一下午晚些時候，醫療保健類股走低，紐約證券交易所醫療保健指數下跌0.2%，道富醫療保健精選行業SPDR ETF (XLV)下跌0.3%。 iShares生物科技ETF (IBB)下跌0.5%。 公司新聞方面，加拿大皇家銀行資本市場(RBC Capital Markets)表示，由於投資者轉向管理式醫療，HCA Healthcare (HCA)可能至少在上半年面臨短期壓力，但3月份的良好趨勢和交易所的良好動態支撐了其長期前景。 RBC重申了對HCA Healthcare的「跑贏大盤」評級，並將目標價從593美元下調至534美元。 HCA Healthcare股價上漲2.3%。
Related Articles
Research
Research Alert: CFRA Retains Buy Opinion On Shares Of Waste Connections Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We update our 12-month target to CAD272 from CAD293, valuing shares with a multiple that is more in line with peers: 14.2x our estimated 2027 EBITDA outlook. We have maintained our 2026 and 2027 EPS forecasts at USD5.72 and USD6.49, respectively. WCN delivered strong Q1 results that exceeded expectations and aligned with our Buy thesis on shares. WCN's secondary market positioning, exposure to specialized waste streams, and focus on quality contracts is enabling solid waste pricing that is supporting both top- and bottom-line expansion. Solid waste core pricing of 6% supported growth, while the company strategically shed lower-margin volumes (down 1.5%), prioritizing profitability over volume - a trend we view favorably across the waste industry. Coupled with a more attractive valuation following a 17% one-year decline, we see upside in shares amid potential commodity price improvements, accretive M&A, and AI investments for operational benefits.
$WCN
Research
Research Alert: CFRA Retains Buy Opinion On Shares Of Waste Connections Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We update our 12-month target to $200 from $215, valuing shares with a multiple that is more in line with peers: 14.2x our estimated 2027 EBITDA outlook. We have maintained our 2026 and 2027 EPS forecasts at $5.72 and $6.49, respectively. WCN delivered strong Q1 results that exceeded expectations and aligned with our Buy thesis on shares. WCN's secondary market positioning, exposure to specialized waste streams, and focus on quality contracts is enabling solid waste pricing that is supporting both top- and bottom-line expansion. Solid waste core pricing of 6% supported growth, while the company strategically shed lower-margin volumes (down 1.5%), prioritizing profitability over volume - a trend we view favorably across the waste industry. Coupled with a more attractive valuation following a 17% one-year decline, we see upside in shares amid potential commodity price improvements, accretive M&A, and AI investments for operational benefits.
$WCN
Research
Research Alert: CFRA Raises Opinion On Shares Of Verizon Communications To Hold From Sell
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We increase our 12-month target price by $10 to $50, applying an EV/EBITDA multiple of 7.4x to our 2026 estimate, comparable to the peer average. We raise our 2026 EPS estimate by $0.03 to $4.93 and increase 2027's by $0.08 to $5.25. VZ's turnaround program is progressing and gaining momentum, powered by a comprehensive transformation program reshaping operations and customer service. The transformation is credited with delivering a strong quarter across core operating metrics, translating performance into solid operational and financial outcomes not seen in over a decade. This feat is impressive given this is Dan Schulman's first full quarter as CEO. As a result of turnaround progress, Verizon raised its guidance for adjusted EPS growth and postpaid phone net adds for 2026. We note that there are still some areas that need to be worked on. Consumer postpaid phone net losses were 35k, despite overall positive net adds, indicating ongoing challenges in the consumer segment.
$VZ